Markers of lutein and zeaxanthin status in two age groups of men and women: dietary intake, serum concentrations, lipid profile and macular pigment optical density
© Olmedilla-Alonso et al.; licensee BioMed Central Ltd. 2014
Received: 7 February 2014
Accepted: 27 May 2014
Published: 3 June 2014
Background & aims
Lutein and zeaxanthin accumulate in retina (macular pigment). Their nutritional status can be assessed using dietary or biochemical markers and both have been associated with macular pigment optical density. We proposed to assess dietary and status markers of lutein and zeaxanthin in a group of healthy Spanish volunteers, considering the potential influence of age, gender and serum lipids to investigate the predictors of the macular pigment optical density.
Serum lutein and zeaxanthin concentrations, dietary intake and macular pigment optical density were determined in 108 healthy men and women (20–35 and 45–65 years), using high-performance liquid chromatography, 3-day food records and heterochromic flicker photometry, respectively. Mann–Whitney U-test, Spearman correlation coefficient and multivariate regression analysis were used for the statistical study.
Serum concentrations and dietary intake of lutein plus zeaxanthin (p < 0.0001 and p = 0.001, respectively) were higher in older vs younger subjects, whereas macular pigment optical density was lower (p = 0.038). The highest correlation coefficients between intake and serum were for fruit and serum lutein (ρ = 0.452, p < 0.0001) and for fruit and lutein + zeaxanthin (ρ = 0.431, p < 0.0001) in the younger group. Macular pigment optical density correlated with serum xanthophylls (ρ = 0.223, p = 0.02) and fruit and vegetable intake (ρ = 0.350, p = 0.0002), showing highest correlations when lutein and zeaxanthin were expressed in relation to serum lipids in older subjects (ρ = 0.262, p = 0.006). Multivariate regression analysis identified age and serum lutein as major predictors of macular pigment optical density (total sample), and a coefficient of determination of 29.7% for the model including lutein + zeaxathin/cholesterol + triglycerides, sex and fruit + vegetables in the older group.
The establishment of normal/reference ranges for serum lutein and zeaxanthin should consider age ranges and be expressed in relation to lipid concentrations, at least in subjects over 45 years, as this could influence macular pigment optical density. The macular pigment optical density showed age-specific correlations with lutein plus zeaxanthin expressed in relation to serum lipid concentrations as well as with the fruit and vegetable intake.
KeywordsLutein Zeaxanthin Serum Dietary intake Macular pigment optical density Lipid profile
Lutein and zeaxanthin are plant pigments that belong to the well-known group of carotenoids, subgroup of xanthophylls (oxycarotenoids), found in the human body (blood, tissues, and concentrated in retina, where they constitute what it is known as the macular pigment [MP]). They are provided only in the diet, and are transported in blood to the different tissues by lipoproteins . Both xanthophylls, but primarily lutein, have been investigated in relation to eye health and disease. They act by filtering blue-light and as antioxidants that may protect macular pigment from oxidative damage induced by light and the high rate of oxidative metabolism in the eye. Moreover, there is increasing evidence suggesting that MP may protect against age-related maculopathy .
Traditionally, exposure to or nutritional status assessment of lutein (generally assessed together with zeaxanthin) in human subjects has routinely been performed using dietary or biochemical methods [2–5]. The dietary intake of lutein and its presence in blood / tissues (i.e. in retina) have been associated with a lower risk for age-related diseases, and the levels increase upon the ingestion of lutein-rich foods and lutein supplements [3, 6, 7]. Determination of serum lutein and zeaxanthin concentrations has been considered the best available method for establishing their nutritional status in human subjects [2, 4, 5], and these concentrations are affected by dietary and host-related factors that influence their absorption and utilization [3, 7]. The lutein concentration in serum is considered to reflect short-term dietary intake and, although it often correlates poorly with said intake, it is widely accepted as a good biomarker of fruit and vegetable intake .
The MP density can be considered a marker of long-term dietary exposure [4, 8] that can be measured by a number of techniques and the most widely used noninvasive test is heterochromatic flicker photometry . Its assessment is increasingly being performed due to new commercially available devices that can easily be employed in clinical practice. To know to what extent macular pigment optical density (MPOD) can be considered a surrogate measure of lutein and zeaxanthin intake and status, we need more data from well-defined, homogeneous populations, with information on the many factors affecting the levels of these compounds. This would shed light on their role in visual function and in the reduction of risk of eye diseases, and allow comparisons between population groups. Dietary and serum lutein and zeaxanthin concentrations have often been positively associated with MP [5, 7, 8], but conflicting results have been reported concerning the influence of several variables (sex [2, 9], age , body mass index (BMI)  and lipids ), among other factors.
This study was designed to assess: 1) dietary and status markers (diet, serum and MPOD) of lutein and zeaxanthin, together with serum lipid profile as a confounding factor and, 2) the predictive value of those compounds and several confounding factors (age, sex, serum lipids) for the MPOD, in a population of well-characterized healthy Spanish volunteers, grouped according to age and gender, as these factors can modify the lutein and zeaxanthin concentrations in the three status markers or the correlations among them.
Materials and methods
Subjects and study design
108 volunteers (54 men and 54 women), divided into two age groups (20 to 35 y and 45 to 65 y) (mean ± SD: 25.6 ± 3.2 y and 52.4 ± 5.2 y, respectively) were enrolled in a cross-sectional study. These age groups were established because of their different dietary habits and risk of age-related ocular disease. Participants were selected from those subjects who were interested and contacted through advertisements in different universities, research centers, and several noticeboards (i.e. intranet of several Spanish ministries). Of the 137 individuals who showed their interest in participating in the study, 5 were excluded because of a high cholesterol level, 4 because they were taking omega-3 food supplements or enriched milk, 2 because of his/her BMI and 19 because their age and sex corresponded to a group in which the established number of subjects had been reached. The inclusion criteria were normal cholesterolemia, BMI under 30 kg/m2, mixed diet (no avoidance of any food groups). Volunteers were asked to report information on the following exclusion criteria: consumption of dietary supplements, BMI under 20 kg/m2, surgery for myopia (within the previous year), cataracts or macular degeneration, use of drugs or phytosterol-enriched beverages/foods to control cholesterol level, regular consumption of n-3 fatty acid-enriched food products and chronic diseases that can affect carotenoid or lipid metabolism (i.e. diabetes, cardiovascular disease).
The volunteers included in this cross-sectional study underwent blood sampling, assessment of the MPOD and 3-day food records. The subjects were enrolled over the course of an entire year (during the spring and summer: 40 in the younger and 29 in the older age group, and, during the fall and winter: 14 in the younger and 25 in the older age group). Blood samples were collected after overnight fast (at least 8 hours) and serum obtained for the analysis of lutein, zeaxanthin and lipid profile.
This study was conducted in accordance with the guidelines laid down in the Declaration of Helsinki and all procedures involving human subjects were approved by the Clinical Research Ethics Committee of Hospital Universitario Puerta de Hierro-Majadahonda of Madrid, Spain (registry no. 257, dated 19 July 2010). Written informed consent was obtained from all subjects.
Lutein, zeaxanthin and lipid analysis in blood
Lutein and zeaxanthin levels were determined by high performance liquid chromatography (HPLC) using a system consisting of a model 600 pump, a Rheodyne injector and a 2998 photodiode array (PDA) detector (Waters, Milford, MA, USA) in accordance with standard procedures described elsewhere . We used a Spheri-5 ODS 5 μm (220 mm × 4.6 mm) chromatographic column (Brownlee Labs, Applied Biosystem, Santa Clara, CA, USA) with a guard column (Aquapore ODS type RP-18). The mobile phase was acetonitrile-methanol (85:15; v/v), and was changed to acetonitrile-dichloromethane-methanol (70:20:10; v/v/v) in a linear gradient from min 5 to min 20. Both mobile phases were stabilized with ammonium acetate (0.025 mol L−1) added to the methanol. The flow rate was 1.8 mL min−1, and detection was performed at a wavelength of 450 nm. All chromatograms were processed using Empower 2 software (Waters, Milford, MA, USA).
Carotenoid extraction was performed on serum samples using a slight modification of a previously published method . Briefly, 200 μl of serum was added to 200 μl of ethanol, vortexed and extracted twice with 400 μl of hexane: dichloromethane (5:1) stabilized with 0.1 g/L butylated hydroxyltoluene. Organic phases were pooled, evaporated to dryness under nitrogen atmosphere and reconstituted with 200 μl of a solution of tetrahydrofuran: ethanol (1:2) and injected (5 μl) onto the HPLC system.
Methanol, ethanol, acetonitrile, dichloromethane, ammonium acetate, butylated hydroxytoluene (BHT) and tetrahydrofuran were supplied by Panreac (Barcelona, Spain). Lutein (xanthophyll from marigold) was obtained from Sigma Chemical Co. (St. Louis, MO, USA) and zeaxanthin was purchased from Fluka Analytica (Sigma Aldrich).
Standard solutions were prepared from 1 mg of lutein and of zeaxanthin dissolved in 25 mL tetrahydrofuran, with 0.01% BHT in each case. The E1cm1% values and wavelengths used were as follows: lutein, 2550 at 445 nm; zeaxanthin, 2540 at 450 nm. Working solutions were obtained from different volumes of the standard solutions dissolved in tetrahydrofuran: ethanol (1:2 v/v). The concentrations of the carotenoids in the curve were: 0.27-1.36 μg mL−1 for lutein (R2 = 0.999) and 0.03-0.15 μg mL−1 for zeaxanthin (R2 = 0.999).
Blood total cholesterol and high-density lipoprotein (HDL) cholesterol were analyzed by colorimetric enzyme assay (Cobas Integra 400 plus, Roche). The low-density lipoprotein (LDL) cholesterol level was calculated with the Friedewald al equation . Serum triglycerides were determined using an enzymatic colorimetric test (Roche Diagnostics, GmbH Manheim, Germany), a method that employs lipase, glycerol kinase, glycerol-3-phosphate oxidase and peroxidase.
Dietary intake assessment
Recent dietary intake was evaluated using 3-day food records involving 24 h recalls, one of which coincided with a weekend or holiday, carried out within a period of 7 to 10 days. For the first recall, the participants underwent a face-to-face encounter with a specialized interviewer, normally the same person who, subsequently, performed the other two recalls by telephone. The amounts consumed were estimated in units (fruits), portions or household servings standardized for this study . On the basis of this information, we calculated food intake in grams/day, which served as the basis for the determination of the daily lutein and zeaxanthin intake using a database designed by our group, included in a software application for the calculation of dietary intake of individual carotenoids . To evaluate the lipid and energy intake, we employed a food composition table widely used in Spain .
Macular pigment optical density (MPOD) assessment
Macular pigment optical density was assessed using an MPS 9000 desktop device (Macular Pigment Screener, Elektron PLC, Cambridge, UK) that applies the principles of heterochromatic flicker photometry. The technique and reliability of this device are described in detail by van der Veen et al. . The test consists of two stages for central and peripheral viewing, and the subjects were required to press a response button as soon as they detect flicker. The subjects started by fixating the central stimulus, a 1-degree central target (flicker rate is initially set to 60 Hz and then gradually reduced at a rate of 6 Hz s−1). The process was repeated for a series of green-blue luminance ratios. The observer then fixated a red 2°-diameter target placed 8° eccentrically and a second set of data were recorded for peripheral viewing . The MPOD is measured in density units (du) and ranges from 0 to 1.
Sample size calculation was performed on the basis of a mean value for MPOD of 0.40 du. A sample of 108 subjects (SD = 0.10) was found to be necessary to obtain a 10% difference in the MPOD (0.04 du) with 85% power and an alpha error of 0.05. Data are expressed as the mean and standard deviation, median and 95% confidence interval. The normal distribution of the data was assessed (Kolmogorov-Smirnov test) and, as lutein and zeaxanthin in serum and diet and serum triglycerides did not follow a normal distribution, the Mann–Whitney U test was used to compare concentrations of the variables analyzed in the two groups (established according to sex and age). Age and sex were introduced as covariates in the generalized linear model and only age affected the concentration/intake of several variables. No interactions were observed for any of the variables except for serum lutein + zeaxanthin/HDL serum which was affected by age and by sex and, HDL-cholesterol which was influenced by sex.
Correlations among variables in serum, diet and the MPOD were established using Spearman’s rho correlation coefficient. All reported P-values are based on a two-sided test and compared to a significance level of 5%.
Multiple linear regression analysis was carried out using backward elimination as a model selection procedure, with macular pigment optical density as dependent variable and the following independent variables: sex, age, lutein and zeaxanthin in serum and in diet, lutein + zeaxanthin in serum and in diet, lutein + zeaxanthin/cholesterol + triglycerides, lutein + zeaxanthin/HDL-cholesterol, lutein + zeaxanthin/LDL-cholesterol and fruit and vegetable consumption. SPSS v.20 (SPSS Inc., Chicago, IL, USA) software was used for all statistical calculations.
Dietary intake and serum concentrations of lutein and zeaxanthin, macular pigment optical density, serum lipids and body mass index in Spanish subjects (n=108) expressed as mean ± standard deviation, (median) and confidence interval [ 95% CI]
Aged 20–35 years
Aged 45–65 years
(n = 54)
(n = 54)
(n = 54)
(n = 54)
(n = 108)
Concentrations in serum
13.0 ± 6.9
12.7 ± 5.5
10.9 ± 5.0b
14.8 ± 6.6b
12.8 ± 6.2
2.9 ± 1.4
2.8 ± 1.3
2.7 ± 1.2
3.0 ± 1.5
2.8 ± 1.4
[2.5 ; 3.2]
Lutein + zeaxanthin (μg/dl)
16.5 ± 8.1
15.6 ± 6.6
14.3 ± 6.5b
17.9 ± 7.8b
16.1 ± 7.4
Lutein + zeaxanthin/cholesterol + triglycerides (μg/mg)
0.06 ± 0.03
0.06 ± 0.03
0.06 ± 0.03
0.06 ± 0.03
0.06 ± 0.03
186.0 ± 42.9
187.1 ± 42.9
165.4 ± 43.2b
207.7 ± 43.1b
186.6 ± 48.0
HDL cholesterol (mg/dl)
52.5 ± 14.1a
62.4 ± 12.8a
55.6 ± 12.9
59.4 ± 15.5
57.5 ± 14.3
LDL cholesterol (mg/dl)
110.7 ± 37.2
109.7 ± 43.6
92.8 ± 35.3b
127.6 ± 37.7b
110.2 ± 40.3
105.7 ± 55.3a
74.5 ± 23.9a
86.3 ± 36.3
94.0 ± 52.7
90.1 ± 45.2
955.4 ± 1418.1
1190.8 ± 1727.4
903.9 ± 1571.8b
1242.3 ± 1579.3b
1073.1 ± 1577.4
78.6 ± 121.1
111.7 ± 155.7
91.5 ± 143.5
98.8 ± 137.2
95.2 ± 139.8
Lutein + zeaxanthin (μg/day)
1052.8 ± 1531.6
1283.7 ± 1860.6
995.4 ± 1705.0b
1341.1 ± 1693.1b
1168.3 ± 1700.0
Lutein + zeaxanthin/1000 Kcal (μg/day)
47.5 ± 71.2
66.8 ± 91.5
47.7 ± 78.4b
66.6 ± 85.4b
57.1 ± 82.2
Macular pigment optical density (density units)
MPOD (n = 216 eyes)
0.352 ± 0.150
0.342 ± 0.155
0.370 ± 0.140b
0.325 ± 0.158b
0.347 ± 0.108
Body mass index (kg/m 2 )
24.9 ± 2.2a
21.8 ± 2.4a
22.7 ± 2.8b
24.0 ± 2.5b
23.4 ± 2.7
The difference in lutein and zeaxanthin between the two age groups disappeared when their concentrations were expressed in relation to serum lipids (cholesterol + triglycerides), but was maintained when intake was expressed in terms of dietary energy density (lutein plus zeaxanthin/1000 kcal). Regarding lipids in serum (all the subjects had serum cholesterol levels within normal range), the total cholesterol and LDL-cholesterol concentrations showed age-related differences (higher in older vs younger subjects), whereas HDL-cholesterol and triglyceride concentrations showed sex-related differences (the former higher in women than in men and the latter vice versa). The mean BMI in the total sample was within normal range (23.4 ± 2.7 kg/m2), being higher in men vs women and in older vs younger subjects (p = 0.002). Finally, there were differences in the MPOD related to age (lower in older vs younger individuals, p = 0.038) but not to sex.
Dietary intake of the major sources of lutein and zeaxanthin intake (g/day) and energy intake expressed as mean ± standard deviation, (median) and confidence interval [ 95% CI]
Aged 20–35 years
Aged 45–65 years
Total sample (n = 108)
Food groups (g/day)
225.4 ± 197.4
223.4 ± 178.6
150.4 ± 119.5b
298.4 ± 213.1b
224.4 ± 187.3
280.8 ± 158.1
269.1 ± 140.1
238.0 ± 128.4b
311.9 ± 159.4b
275.0 ± 148.8
Fruit + vegetables
506.2 ± 278.2
492.5 ± 265.6
388.4 ± 190.2b
610.3 ± 294.6b
499.3 ± 270.8
25.8 ± 28.5
24.8 ± 21.8
25.7 ± 24.8
24.9 ± 26.0
25.3 ± 25.3
Energy intake (Kcal)
2334 ± 584a
1895 ± 402a
2096 ± 494
2133 ± 597
2114 ± 546
Correlations between diet and serum concentrations of lutein and zeaxanthin and their major food sources
Correlations (Spearman’s ρ and ( p value)) between lutein, zeaxanthin and major food sources for dietary intake and serum concentrations
Aged 20 – 35 years
Aged 45 – 65 years
Lutein + Zeaxanthin
Lutein + Zeaxanthin
Lutein + Zeaxanthin
0.238 ( 0.083)
Lutein + zeaxanthin
Lutein + zeaxanthin (density)
Fruit and vegetables
Egg consumption, a good source of lutein, is lower than the Spanish mean intake (32 g/day) , showed a wide variability and had a significant inverse correlation with the serum lutein and zeaxanthin concentrations in the older group. The degree of correlation loses statistical significance if only those individuals who consumed eggs are assessed.
Correlations of lutein and zeaxanthin in diet and serum and the major sources of their dietary intake with macular pigment optical density
Statistically significant correlations (Spearman’s ρ and ( p value)) between lutein, zeaxanthin and major food sources for their intake in serum and diet with MPOD (two eyes/subject, n=216)
Aged 45 – 65 years
Lutein + zeaxanthin
Lutein + zeaxanthin/cholesterol + triglycerides
Lutein/cholesterol + triglycerides
Zeaxanthin/cholesterol + triglycerides
Lutein + zeaxanthin/HDL-cholesterol
Lutein + zeaxanthin/LDL-cholesterol
Fruit and vegetables
The MPOD showed age-specific correlations with lutein plus zeaxanthin expressed in relation to serum lipid concentrations as well as with the fruit and vegetable intake.
Multivariate regression analysis of dietary and biochemical factors associated with the MPOD
Multivariate regression analysis of biochemical and dietary factors, sex and age data associated with MPOD
- 0.094 (0.023)
- 0.139, −0.048
Older group (45–65 y)
- 0.086 (0.027)
- 0.139, −0.032
Lutein + zeaxanthin/cholesterol + triglycerides
Lutein status is routinely assessed together with zeaxanthin, using dietary or biochemical methods, both of which have advantages and limitations, although serum concentration has been considered the best method for establishing their nutritional status in humans . Different factors linked either to the subject or to diet can influence their concentrations in serum and their bioavailability [3, 7, 10]. For this report, we selected a sample of apparently healthy subjects with similar serum lipids, body weight and dietary habits (varied diet and no dietary supplements) from two different age groups having the same proportion of men and women. To our knowledge, this is the first study to simultaneously assess dietary and status markers of lutein and zeaxanthin (diet, serum and MPOD) in Spanish subjects taking into account several confounding factors.
Serum lutein and zeaxanthin concentrations are similar to those reported in other groups of Spanish subjects  and somewhat lower than [4, 10] or similar to [1, 19, 20] those of comparable age in several European and North American countries. Serum lutein concentrations in the present study, and in practically all those mentioned above, are much lower than the >34 μg/dL (0.6 μmol/L) that seem to be consistently associated with lower risk in epidemiological studies (including lower risk for age-related macular degeneration and cataracts) and higher MPOD .
We observed no sex differences in serum concentrations and dietary intake of lutein and zeaxanthin or in MPOD, findings reported in a number of studies [4, 20–22], although other authors observed higher intake in women . In contrast, although cholesterol was within normal range, there were differences in serum lipids, and higher triglyceride and lower HDL-cholesterol levels were observed in men. However, serum lutein and zeaxanthin concentrations differed according to the age group, being higher in the older subjects. Their intake, both crude and energy-adjusted, is also greater, as reported elsewhere , and this group consumes more fruits and vegetables, as well. These differences disappear when serum concentrations are related to levels of circulating lipids (lutein + zeaxanthin/cholesterol + triglycerides), transporters of these xanthophylls, which are being considered for a better interpretation of the antioxidant/nutritional status [11, 25] or are expressed as 1000 kcal intake. The MPOD in the total sample was 0.35 du, similar to that of other studies [21, 22, 26], and differed according to age .
However, the amount of lutein plus zeaxanthin intake (median value) is much lower than that found by our group more than a decade ago in European subjects (n = 400) . In that study, the intake in the Spanish subgroup (n = 80) was 3.25 mg/day (range: 1.8-4.3 mg/d), which contrasts with the 0.45 mg/d of this study, which, in turn, is similar to the mean intake in the Spanish population obtained in national surveys (0.5 mg and 0.1 mg/person/day of lutein and zeaxanthin, respectively) . It is also similar to the levels reported in other populations . If we compare the mean intake usually found in the literature, rather than the median value (preferable since the data usually do not follow a normal distribution), the mean intake of 1.2 mg is similar or slightly below the range described in other studies [6, 8, 21, 24].
The different intake levels found in the literature are largely attributable to the differences among databases for carotenoid composition in foods and the types of dietary questionnaires employed . Regarding the aforementioned European study, the food composition data utilized are very similar to those used in this report  since, in both cases, much of the data resulted from HPLC analysis of Spanish foods; however, the European study was based on a semiquantitative food frequency questionnaire (FFQ), whereas in the present study, 3-day food records were employed. FFQ have been reported to overestimate carotenoid intake , especially that of lutein and zeaxanthin when comparing these two methods . FFQ were used in those studies in which intake concentrations were higher and 2 or 3-day recalls were employed in others in which the concentrations were comparable. On the other hand, the data from population-based studies in the USA and Spain indicate that levels of lutein and zeaxanthin intake have declined, particularly from dark-green leafy vegetables . Another aspect to be considered regarding lutein intake is food seasonality; however, in the Spanish population, the mean intake of lutein has been reported to be relatively constant throughout the year .
Concerning the sex differences in lutein and zeaxanthin intake, the results in the literature are inconsistent, indicating a higher intake among women [22, 23], in whom a lower energy intake  or no differences  are likewise reported. There are also discrepancies in the findings according to age group, with some studies that show no differences  and others that do; in the later, as in our study, a higher intake is reported for older individuals .
Lutein intake is higher than that of zeaxanthin in all populations [6, 20]; in a typical western diet, a ratio of 7:1 (lutein:zeaxanthin) has been reported . This is lower than that found in our study, which is 11:1 in the total sample and 13:1 in the older subjects, who consume more fruit and vegetables (Table 2) than the younger participants (10:1). The mean intake of fruits and vegetables is higher than that recommended by the WHO to decrease risk of chronic diseases (400 g/day).
The degree of correlation between lutein and zeaxanthin concentrations in serum and diet is significant, being higher if determined by dietary intake of fruit and vegetables, rather than by measuring the concentrations of these xanthophylls as provided by the diet (Table 3). The Pearson correlation coefficient between their serum concentrations and dietary intake is >0.2 and is >0.3 when serum concentrations correlate with food consumed, as in other studies [8, 21, 22, 26]. Aside from the amount injested, the degrees of correlation between biological markers, apparently low, are influenced by many other subject-related factors (i.e. sex, age, BMI, eating habits, sample size), as well as metabolic factors [2, 8], and in our study, the degrees of correlation were found to vary according to age group, but not sex. Thus, in younger subjects, there is a correlation between serum levels and dietary intake (in terms of both the concentrations of these compounds intake density) whereas, in older subjects correlation was observed only for zeaxanthin, despite the fact that these individuals have higher levels both in their intake and in serum. Therefore, other metabolic factors must influence metabolism of these xanthophylls, such as the uptake of lutein and zeaxanthin from plasma and their transport to the retina (e.g. serum lipid levels, or binding protein in optical tissue with binding capacity for zeaxanthin isomers, but not for lutein) . Correlation in young subjects but not in their elders has been reported by other authors . However, the correlations between serum concentrations and fruit and vegetable intake are significant in both age groups, especially for fruit intake.
The concentration of lutein and zeaxanthin in the retina, assessed by MPOD, was lower in the older subjects, despite the fact that their intake was higher than that of younger individuals (also expressed in relation to 1000 kcal). These higher intakes are reflected in the higher serum concentrations, although the differences disappear when the levels are expressed in relation to serum lipids. Correlations between MPOD and serum lutein and zeaxanthin and dietary intake reached the highest significance level for zeaxanthin and for lutein + zeaxanthin in relation to lipids (cholesterol + triglycerides, LDL-cholesterol and HDL-cholesterol) and when related to diet (lutein density and fruits and vegetables) (Table 4). Lutein and zeaxanthin are transported in LDL and HDL in similar amounts and it is widely accepted that oxidative modifications of LDL and HDL affect lipoprotein metabolism and modified LDL may have an effect on retinal pigment epithelial cells .
There are significant correlations in the elderly group, but not in the younger group (except the correlation with the lutein intake expressed as concentration per 1000 kcal, [ρ = −0.214, p = 0.026]). Although, MPOD is often positively associated with dietary and serum lutein and zeaxanthin concentrations , conflicting results have been reported on the influence of sex , age , BMI [2, 31], and other postprandial or environmental factors (e.g. smoking) . The highest correlations between MPOD and lutein and zeaxanthin in serum and dietary intake correspond to fruit and vegetables (ρ = 0.35) and to lutein + zeaxanthin/HDL-cholesterol (ρ = 0.301); the latter is consistent with the identification of HDL as the specific transporter of lutein and zeaxanthin to retina in chicks . The strong correlation between MPOD and fruit and vegetable intake, also reported elsewhere , indicates that not only the amounts of lutein and zeaxanthin are important for ocular tissue; there are other micronutrients and bioactive compounds in these foods that are also beneficial (e.g. fiber and polyunsaturated fatty acid intake are also directly related to MPOD) . On the other hand, few studies have assessed lutein and zeaxanthin status simultaneously using the three possible markers (diet, serum and MPOD) and these studies are not very homogeneous in terms of factors that can exert an influence such as sex, age, serum lipids and BMI, among others [21, 22, 26]. Nevertheless, although consistent associations among these three markers have not always been found, most studies point to the protective role of a diet rich in fruits and vegetables. However, in multivariate regression analysis, performed to assess the predictive value of lutein and zeaxanthin concentrations in serum and dietary intake, sex, age and the concentrations of different serum lipids for MPOD, only the serum lutein concentration and lutein + zeaxanthin in relation to cholesterol + triglycerides, but not fruit and vegetable intake, correlate with MPOD. Moreover, age is an important predictor in the total sample, as is sex in the older group, although we observed no sex differences in the MPOD values in this study, a fact that could be explained if the availability of lutein and zeaxanthin to the retina could be influenced by physiological sex differences  (i.e. if binding protein in optical tissue specific for zeaxanthin responds differently in men and women ).
In conclusion, lutein and zeaxanthin concentrations in serum and dietary intake of these xanthophylls and of their major food sources are higher in older vs younger subjects; however, MPOD is lower. In younger individuals, MPOD is influenced by serum lutein but, in older individuals, the presence of lutein plus zeaxanthin in relation to circulating lipids is a determining factor. Thus, when establishing normal/reference ranges for serum lutein and zeaxanthin, age ranges should be taken into account and the levels of these xanthophylls should be expressed in relation to the lipid concentration, at least in subjects over 45 years of age, as this could influence MPOD.
Macular pigment optical density
Body mass index
High density lipoprotein
Low density lipoprotein.
The authors wish to thank Maria Luisa García-González for technical support, Susana Jiménez-Redondo for their support in dietary assessment and Martha Messman for English editing.
This study was supported by grant from Acción Estratégica en Salud of the Instituto de Salud Carlos III (Ministerio de Ciencia e Innovación Tecnológica, Spain) (grant no. PS09/00681) and Rocío Estévez Santiago is the recipient of a JAEPredoc grant from the Consejo Superior de Investigaciones Científicas (CSIC), awarded under the program of the Junta para la Ampliación de Estudios, co-financed by the European Social Fund (ESF).
We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI).
- Renzi LM, Hammond BR, Dengler M, Roberts R: The relation between serum lipids and lutein and zeaxanthin in the serum and retina: results from cross-sectional, case–control and case study designs. Lipids Health Dis. 2012, 11: 33-10.1186/1476-511X-11-33.View Article
- Carpentier S: Associations between Lutein, Zeaxanthin, and age-related macular degeneration: an overview. Crit Rev Food Sci. 2009, 49: 313-326. 10.1080/10408390802066979.View Article
- Granado F, Olmedilla B, Blanco I: Nutritional and clinical relevance of lutein in human health. Br J Nutr. 2003, 90 (3): 487-502. 10.1079/BJN2003927.View Article
- Cardinault N, Gorrand J-M, Tyssandier V, Grolier P, Rock E, Borel P: Short-term supplementation with lutein affects biomarkers of lutein status similarly in young and elderly subjects. Exp Gerontol. 2003, 38: 573-582. 10.1016/S0531-5565(03)00039-1.View Article
- Lien EL, Hammond BR: Nutritional influences on visual development and function. Prog Retin Eye Res. 2011, 30: 188-203. 10.1016/j.preteyeres.2011.01.001.View Article
- Shardell M, Alley D, Hick G, El-Kamary S: Low-serum carotenoid concentrations and carotenoid interactions predict mortality in US adults: the Third National Health and Nutrition Examination Survey. Nutr Res. 2011, 31: 178-189. 10.1016/j.nutres.2011.03.003.View Article
- Thurnham DI: Macular zeaxanthins and lutein - a review of dietary sources and bioavailability and some relationships with macular pigment optical density and age-related macular disease. Nutr Res Rev. 2007, 20 (2): 163-179. 10.1017/S0954422407842235.View Article
- Beatty S, Nolan J: Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeaxanthin. Arch Biochem Biophys. 2004, 430: 70-76. 10.1016/j.abb.2004.03.015.View Article
- Murray IJ: Macular pigment: characteristics and role in the older eye. The New Visual Neurosciences. Edited by: Werner JS, Chalupa LM. 2014, London, England: The MIT Press
- Curran-Celentano J, Hammond BR, Ciulla TA, Cooper DA, Pratt LM, Danis RB: Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr. 2001, 74 (6): 796-802.
- Gross M, Yu XH, Hannan P, Prouty C, Jacobs DR: Lipid standardization of serum fat-soluble antioxidant concentrations: the YALTA study. Am J Clin Nutr. 2003, 77 (2): 458-466.
- Granado-Lorencio F, Olmedilla-Alonso B, Blanco-Navarro I, Botella-Romero F, Simal-Anton A: Assessment of carotenoid status and the relation to glycaemic control in type I diabetics: a follow-up study. Eur J Clin Nutr. 2006, 60 (8): 1000-1008. 10.1038/sj.ejcn.1602411.View Article
- Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502.
- Moreiras O, Carbajal A, Cabrera L, Cuadrado C: Tablas de Composición de Alimentos. 2011, Madrid: Ediciones Pirámide
- Estévez-Santiago R, Beltrán-de-Miguel B, Cuadrado-Vives C, Olmedilla-Alonso B: Software application for the calculation of dietary intake of individual carotenoids and of its contribution to vitamin A intake. Nutr Hosp. 2013, 28 (3): 823-829.
- van der Veen RLP, Berendschot TTJM, Hendrikse F, Carden D, Makridaki M, Murray IJ: A new desktop instrument for measuring macular pigment optical density based on a novel technique for setting flicker thresholds. Ophthal Phys Opt. 2009, 29 (2): 127-137. 10.1111/j.1475-1313.2008.00618.x.View Article
- Makridaki M, Carden D, Murray IJ: Macular pigment measurement in clinics: controlling the effect of the ageing media. Ophthal Phys Opt. 2009, 29 (3): 338-344. 10.1111/j.1475-1313.2009.00667.x.View Article
- MAPA (Ministerio de Agricultura Pesca y Alimentación) / FEN (Fundación Española de la Nutrición): Valoración de la dieta española de acuerdo al panel de consumo alimentario del Ministerio de Agricultura Pesca y Alimentación (MAPA). 2008, Madrid, Spain: Ministerio de Medio Ambiente y Medio Rural y Marino ed
- Nolan JM, Stack J, O'Connell E, Beatty S: The relationships between macular pigment optical density and its constituent carotenoids in diet and serum. Inv Ophthalmol Vis Sci. 2007, 48 (2): 571-582. 10.1167/iovs.06-0864.View Article
- Olmedilla B, Granado F, Southon S, Wright AJA, Blanco I, Gil-Martinez E, Berg H, Corridan B, Roussel AM, Chopra M, Thurnham DI: Serum concentrations of carotenoids and vitamins A, E, and C in control subjects from five European countries. Br J Nutr. 2001, 85 (2): 227-238. 10.1079/BJN2000248.View Article
- Hammond BR, Curran-Celentano J, Judd S, Fuld K, Krinsky NI, Wooten BR, Snodderly DM: Sex differences in macular pigment optical density: relation to plasma carotenoid concentrations and dietary patterns. Vis Res. 1996, 36 (13): 2001-2012. 10.1016/0042-6989(95)00290-1.View Article
- Wenzel AJ, Sheehan JP, Burke JD, Lefsrud MG, Curran-Celentano J: Dietary intake and serum concentrations of lutein and zeaxanthin, but not macular pigment optical density, are related in spouses. Nutr Res. 2007, 27 (8): 462-469. 10.1016/j.nutres.2007.05.011.View Article
- George SM, Thompson FE, Midthune D, Subar AF, Berrigan D, Schatzkin A, Potischman N: Strength of the relationships between three self-reported dietary intake instruments and serum carotenoids: the Observing energy and protein Nutrition (OPEN) Study. Pubic Health Nutr. 2012, 15 (6): 1000-1007. 10.1017/S1368980011003272.View Article
- Johnson EJ, Maras JE, Rasmussen HM, Tucker KL: Intake of Lutein and Zeaxanthin differ with age, sex, and ethnicity. J Am Diet Assoc. 2010, 110 (9): 1357-1362. 10.1016/j.jada.2010.06.009.View Article
- Wei W, Connor SL, Johnson EJ, Klein ML, Hughes S, Connor WE: Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration. Am J Clin Nutr. 2007, 85 (3): 762-769.
- Burke JD, Curran-Celentano J, Wenzel AJ: Diet and serum carotenoid concentrations affect macular pigment optical density in adults 45 years and older. J Nutr. 2005, 135 (5): 1208-1214.
- O’Neill ME, Carroll Y, Corridan B, Olmedilla B, Granado F, Blanco I, Van den Berg H, Hininger I, Rousell AM, Chopra M, Southon S, Thurnham DI: A European carotenoid database to assess carotenoid intakes and its use in a five-country comparative study. Brit J Nutr. 2001, 85: 499-507. 10.1079/BJN2000284.View Article
- Granado F, Olmedilla B, Blanco I, Rojas Hidalgo E: Major fruit and vegetable contributors to the main serum carotenoids in the Spanish diet. Eur J Clin Nutr. 1996, 50 (4): 246-250.
- Granado F, Blázquez S, Olmedilla B: Changes in carotenoid intake from fruit and vegetables in Spanish population over the period 1964–2004. Public Health Nutr. 2007, 10 (10): 1018-1023.View Article
- Du M, Wu M, Fu D, Yang S, Chen J, Wilson K, Lyons TJ: Effects of modified LDL and HDL on retinal pigment epithelial cells: a role in diabetic retinopathy?. Diabetologia. 2013, 56 (10): 2318-2328. 10.1007/s00125-013-2986-x.View Article
- Johnson EJ, Hammond BR, Yeum K-J, Qin J, Dong Wang X, Castaneda C, Snodderly DM, Russell RM: Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr. 2000, 71: 1555-1562.
- Connor WE, Duell PB, Kean R, Wang Y: The prime role of HDL to transport lutein into the retina: evidence from HDL-deficient WHAM chicks having a mutant ABCA1 transporter. Inv Ophthalmol Vis Sci. 2007, 48 (9): 4226-4231. 10.1167/iovs.06-1275.View Article
- Mares J, LaRowe TL, Snodderly DM, Moeller SM, Gruber MJ, Klein ML, Wooten BR, Johnson EJ, Chappell RJ, CAREDS Macular Pigment Study Group and Investigators: Predictors of optical density of lutein and zeaxanthin in retinas of older women in the carotenoids in age-related eye disease study, an ancillary study of the women’s health initiative. Am J Clin Nutr. 2006, 84: 1107-1122.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.